Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in an urgent need for identifying potential therapeutic drugs. In the first half of 2020 tropic antimalarial drugs, such as chloroquine (CQ) or hydroxochloroquine (HCQ) were the focus of tremendous public attention. In the initial periods of th...
Main Authors: | Orsolya Kapuy, Tamás Korcsmáros |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0266337 |
Similar Items
-
Oscillation of Autophagy Induction under Cellular Stress and What Lies behind It, a Systems Biology Study
by: Bence Hajdú, et al.
Published: (2023-04-01) -
Systems-Level Feedbacks of NRF2 Controlling Autophagy upon Oxidative Stress Response
by: Orsolya Kapuy, et al.
Published: (2018-03-01) -
Therapeutic Approach of KRAS Mutant Tumours by the Combination of Pharmacologic Ascorbate and Chloroquine
by: Orsolya Kapuy, et al.
Published: (2021-04-01) -
Hypertension related toxicity of chloroquine explains its failure against COVID-19: Based on rat model
by: Junqi Wang, et al.
Published: (2022-11-01) -
Role of autophagy in glycogen breakdown and its relevance to chloroquine myopathy.
by: Jonathan Zirin, et al.
Published: (2013-11-01)